Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Sugars × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 13 Plasma cell 4 Genitourinary 4 Thoracic 3 Lymphoid 3 Head & Neck 3 Other hematologic neoplasm 2 Other 2 Gynecologic 2 Gastrointestinal 2 Dermatologic 2 Tumor-Agnostic 1 Sarcoma 1 Other solid neoplasm 1 Myeloid 1 Classical hematology 1 CNS 1

Conditions

Interventions

Temozolomide 56 Cyclophosphamide 49 Radiotherapy 48 Bevacizumab 46 Doxorubicin 45 Ifosfamide 32 pazopanib 25 fludarabine phosphate 25 Etoposide 25 Radiation 21 Sunitinib 20 Irinotecan 20 Filgrastim 20 pembrolizumab 19 Sirolimus 19 Gemcitabine 19 Whole-Body Irradiation 18 Vincristine 18 Mycophenolic Acid 18 Imatinib Mesylate 18 Peripheral Blood Stem Cell Transplantation 16 Methotrexate 15 Sorafenib 14 Magnetic Resonance Spectroscopy 14 Carboplatin 14 Busulfan 14 fludarabine 13 Cyclosporine 13 Melphalan 12 Granulocyte Colony-Stimulating Factor 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02606461 2023-01-23

SEAL

Karyopharm Therapeutics Inc

Phase 2/3 Completed

342 enrolled 36 charts

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡